Announcement no. 74/2019
9 December 2019

New R&D leadership

Kim de Roy, EVP
of Research & Development (R&D), is leaving Össur after leading
the R&D
function for the last 2 years.

As of today, Dr. Kristleifur Kristjansson has
been appointed EVP of R&D and will
become a member of Össur's Executive
Management. Dr. Kristjansson joined Össur
in 2012, for the first 5 years as
Medical Officer and in the last 2 years as
Medical Officer and VP of Clinical
Affairs. Dr. Kristjansson holds a Medical
Doctor degree from the University of
Iceland and is a Board-Certified
Pediatrician from the Medical College of
Georgia, in addition to completing a
clinical and molecular genetics fellowship
from the Baylor College of Medicine
in Houston, Texas and has been a certified
Pediatrician and Clinical Geneticist
in Iceland from 1993. Dr. Kristjansson’s
previous positions include co-founder
and VP of Clinical Affairs and
Collaborations at deCODE genetics ehf. 1995 to
2012 and co-founder and CEO of
Pediatric Services in Iceland 1995 to 2014. Dr.
Kristjansson has acted as a
consulting Pediatrician and Clinical Geneticist for
the University Hospital,
Landspitalinn Reykjavik Iceland, from 1998 to the
present, and he is the
Founder and Chairman of the Board of Skraeda ehf.

Jon Sigurdsson, President &
CEO, comments:

"Dr. Kristleifur Kristjansson brings with him a wealth of
experience and
expertise and he has been a valuable member of our team for the
last 7 years.
For the last 2 years Kim de Roy has been an instrumental force in
driving our
innovation strategy. On behalf of all Össur employees I thank him
for his
contribution to Össur."

Further information

David Hreidarsson,
Investor Relations, dhreidarsson@ossur.com, +354 515 1380

Össur press releases
by e-mail

If you wish to receive Össur press releases by e-mail please
register at
http://www.ossur.com/investors

About Össur

Össur (NASDAQ OMX:
OSSR) is a global leader in non-invasive orthopaedics that
help people live a
life without limitations. Its business is focused on
improving people’s
mobility through the delivery of innovative technologies
within the fields of
Prosthetics and Bracing & Supports. A recognized
“Technology Pioneer,” Össur
invests significantly in research and product
development—its award-winning
designs ensuring a consistently strong position in
the market. Successful
patient and clinical outcomes are further empowered via
Össur’s educational
programs and business solutions. Headquartered in Iceland,
Össur has major
operations in the Americas, Europe and Asia, with additional
distributors
worldwide. www.ossur.com